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was isolated from 44 patients, 33 (31%) each from skin and from 
nares. Colonization was highest in erythrodermic SS (48%), simi-
lar to atopic dermatitis (64%), and lowest in MF without erythro-
derma (26%), psoriasis (21%), and the general population (10%). 
Oral and topical antibiotics eradicated S. aureus colonization in 
nares in 28 of 33 (85%) patients and in MF skin lesions in 30 of 
33 (91%) patients at 4–8 weeks, with rapid clinical improvement 
seen in 58% of S. aureus-colonized patients. Staphylococcal car-
riage in nares and skin lesions of patients with MF is similar to that 
in atopic dermatitis. Eradication of staphylococci from the skin is 
possible with treatment and was associated with clinical improve-
ment. Br J Dermatol 2008; 158:105–12.
Fluorescence lifetime imaging distinguishes 
basal cell carcinoma from surrounding 
uninvolved skin
This study aimed to establish whether fluorescence lifetime imag-
ing (FLIM) of skin can provide useful contrast between basal cell 
carcinomas (BCCs) and surrounding uninvolved skin. Significant 
reductions in mean fluorescence lifetimes between areas of BCC 
and areas of surrounding uninvolved skin were demonstrated 
(P < 0.0001). These differences were apparent irrespective of the 
decay model used to calculate the fluorescence lifetimes (single 
vs. stretched exponential) or the long-pass filter through which the 
emitted autofluorescence was collected (375 vs. 455 nm). Results 
suggested that FLIM has a potential future clinical role in imaging 
BCCs for rapid and noninvasive tumour delineation and as an aid 
to determine adequate excision margins with best preservation of 
normal tissue. Br J Dermatol 2008; 158:152–61.
The quality of life of 790 patients  
with photodermatoses
This study assessed and compared the impact of all forms of photo-
dermatoses on patients’ quality of life (QoL) using the standard 
1-week Dermatology Life Quality Index (DLQI) questionnaire and 
a modified questionnaire to assess the impact over the previous 
year. Of 1877 patients contacted, 797 (42%) replied, with a range 
from 30% to 48% for the five individual centres. Nearly two-thirds 
of patients with actinic prurigo (AP) and more than one-third of 
patients with photoaggravated dermatoses (PAD), chronic actinic 
dermatitis, erythropoietic protoporphyria (EPP) and solar urticaria 
had a DLQI of > 10, confirming a very large effect of the disorders 
on QoL. Of the cutaneous porphyrias, both variegate porphyria 
(median DLQI 3) and porphyria cutanea tarda (median DLQI 1.5) 
had a much lower impact on QoL than EPP. Photodermatoses have 
a major impact on QoL: this impact is highest in AP and PAD. Br J 
Dermatol 2008; 158:192–97.
Relationship of protoporphyrin IX synthesis 
to photodynamic effects by 5-aminolaevulinic 
acid and its esters on various cell lines derived 
from the skin
5-Aminolaevulinic acid (ALA) and its esters act as precursors to the 
fluorescent photosensitizer protoporphyrin IX (PpIX) in photody-
namic therapy. Using four cell lines, including human epidermal 
keratinocytes, human dermal fibroblasts, A431 and TXM13, Lee 
et al. studied the amount of PpIX synthesis induced by ALA and 
its esters in skin cell lines, and evaluated the relationship of PpIX 
synthesis to photodynamic effects by ALA and its esters in vitro. 
PpIX production by ALA and its esters was induced on both nor-
mal and malignant cell lines derived from the skin, and cell death 
was more closely related to the amount of PpIX synthesis than to 
the irradiation dose. Br J Dermatol 2008; 158:61–7.
Relevance of compartmentalization  
of T-cell subsets for clinical  
improvement in psoriasis: effect of  
immune-targeted antipsoriatic therapies
In order to gain more insight into the dynamics of compart-
mentalization of T cells between peripheral blood and lesional 
skin of patients with psoriasis in response to immune-targeted 
antipsoriatic therapies, van Lingen et al. studied T-cell counts 
and subsets in the skin of nine patients with psoriasis receiving 
etanercept and nine receiving efalizumab. Treatment with efali-
zumab established successful recompartmentalization of T-cell 
subsets with modest clinical efficacy after 12 weeks, whereas 
in etanercept-treated patients a significant clinical response was 
no guarantee for significant changes in T-cell subsets in the dif-
ferent compartments. Reductions in T-cell subsets cannot be 
used as predictive markers for the clinical response to therapy. 
Interference with the studied T-cell populations in its own right 
seems not to be responsible for the clinical efficacy of efalizum-
ab and etanercept. Br J Dermatol 2008; 158:91–6.
Prevalence and treatment of Staphylococcus 
aureus colonization in patients with mycosis 
fungoides and Sézary syndrome
Talpur et al. studied patients with mycosis fungoides (MF) and 
Sézary syndrome (SS) to see if there was Staphylococcus aureus 
carriage in nares and skin and whether eradication led to a clinical 
improvement. Among 106 patients, 67 (63%) had skin coloniza-
tion and 57 (54%) had nasal colonization. Staphylococcus aureus 
